Objective. To review acute pain management strategies in patients undergoing amputation with consideration of preoperative patient factors, pharmacologic/interventional modalities, and multidisciplinary care models to alleviate suffering in the immediate post-amputation setting.
Background. Regardless of surgical indication, patients undergoing amputation suffer from significant residual limb pain and phantom limb pain in the acute postoperative phase. Most studies have primarily focused on strategies to prevent persistent pain with inclusion of immediate postoperative outcomes as secondary measures. Pharmacologic agents, including gabapentin, ketamine, and calcitonin, and interventional modalities such as neuraxial and perineural catheters, have been examined in the perioperative period.
Design. Focused Literature Review
Results. Pharmacologic agents (gabapentin, ketamine, calcitonin) have not shown consistent efficacy. Neuraxial analgesia has demonstrated both an opioid sparing and analgesic benefit while results have been mixed regarding perineural catheters in the immediate post-amputation setting. However, several early studies of perineural catheters employed sub-optimal techniques (distal surgical placement), and prolonged use of perineural catheters may provide a sustained benefit. Regardless of analgesic technique, a multidisciplinary approach is necessary for optimal care.
Conclusion. Patient-tailored analgesic regimens utilizing catheter-based techniques are essential in the acute post-amputation phase and should be implemented in all patients undergoing amputation. Future research should focus on improved measurement of acute pain and comparisons of effective analgesic regimens instead of single techniques.
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In the United States, approximately 185,000 limb amputations are performed annually [1] . Two million amputees reside in the United States with estimates suggesting that this population will surpass 3.6 million by 2050 [2] [3] [4] [5] . The burden of persistent phantom limb pain (PLP) and residual limb pain (RLP) in this population has been well described with prevalence ranging from 51% to 85% for PLP and 45% to 74% for RLP [6] [7] [8] [9] [10] [11] . While the disease states necessitating amputation may differ, the incidence of PLP and RLP appears to remain consistent across various etiologies. In recent years, there have been several studies investigating the impact of perioperative analgesic interventions on the incidence of chronic pain. However, there has been a more limited focus on the effects of acute interventions in the immediate perioperative period.
Acute pain after amputation continues to be a significant clinical problem. Recently, Raichle et al. in a prospective observational study examined 69 patients scheduled to undergo lower extremity amputation. These patients were questioned regarding anxiety, PLP, and RLP within the first five postoperative days and up to 2 years after amputation [12] . During the first few postoperative days, over 30% of patients reported moderate to severe RLP and more than 25% of patients reported moderate to severe PLP [12] . Gerbenshagen et al. examined postsurgical pain in 179 surgical groups where patients undergoing limb amputation reported median numerical rating scores within a moderate range [13] . Surprisingly only 20% of patients received a regional anesthetic as a component of their analgesic regimen [13] . An even higher incidence of acute post-amputation pain was noted by Hanley et al. who described moderate to severe phantom and residual limb pain in 32% and 53% of patients, respectively [14] . One might postulate that it was the relative absence of regional analgesic catheters that led to a higher burden of acute postoperative pain; however, this conclusion may be oversimplified. Even in a study that utilized perineural catheters in all patients, Borghi et al. still reported nearly uniform moderate to severe acute postoperative pain [15] .
In this review we detail surgical considerations, associated pain mechanisms, and patient specific risk factors to build a framework for optimizing the perioperative pain management of the amputation patient. We also discuss future clinical and research considerations to further improve acute pain management strategies in this patient population. A summary of essential points is found in Box 1.
Methods
The goal of this review is to provide a focused evaluation of the literature examining the management of acute post-amputation pain. Our intent was to highlight studies looking at analgesic outcomes within the first seven postoperative days. As this includes a broad array of variables such as incidence of acute pain, pharmacologic, non-pharmacologic, and interventional modalities, a true systematic review was not practical.
Numerous systematic and topical reviews have been published regarding the treatment of persistent phantom limb and residual limb pain [16] [17] [18] [19] [20] [21] . Most recently, McCormick et al. performed an extensive focused systematic review of pharmacologic based therapies for persistent phantom limb pain [16] . Here we focus on prevention and treatment of acute residual limb and phantom limb pain. The vast majority of reviews (both topical and systematic) and source studies included here focused on chronic post-amputation pain as a primary outcome. Few if any studies were powered to measure acute perioperative pain variables as primary outcomes. While randomized controlled trials were emphasized, some small prospective series or retrospective analyses were included if reporting novel strategies or if a paucity of evidence existed in regards to a specific treatment strategy. Case reports were excluded. For those studies included, levels of evidence were assigned in a similar fashion to McCormick et al. (Table 1) [16].
Surgical Considerations
The majority of lower limb amputations occur secondary to ischemia, while trauma is the leading cause of amputation of the upper extremity [2, 22] . Regardless of etiology, surgical technique focuses on salvaging tissue to maximize postsurgical mechanical function. A variety of
Box 1 Essential Points
• Patients undergoing amputation commonly suffer immediate moderate to severe postoperative pain.
• Preoperative pain, opioid use, and anxiety have been linked to worse postoperative pain scores.
• Pharmacologic and interventional techniques should follow a multimodal approach with low thresholds for the use of catheter-based regimens and the use of gabapentanoids and/or ketamine ( Figure 1 ).
• In most cases, neuraxial and proximally placed perineural catheters should be utilized in preference to surgically placed perineural catheters.
• No consistent therapy has been shown to prevent persistent residual limb pain or phantom limb pain.
• Perioperative pain management should follow a multidisciplinary approach involving the acute pain medicine service.
• Perioperative pain assessments should expand beyond pain intensity and opioid use and include biopsychosocial measures such as pain interference and physical function. general surgical principles are followed such as gentle handling of soft tissues, clean transection of nerves, and appropriate engagement of muscular tissue through myodesis or myoplasty [23] . A clean and proximal nerve transection is of great importance. Without retraction of the nerve into muscle tissue, patients may experience an increased risk of a sensitized neuroma at the interface of the distal stump and the prosthesis. While a variety of surgical techniques such as targeted nerve implantation or traction neurectomy has been attempted to prevent or treat neuroma formation, little is known regarding perioperative analgesic techniques that minimize the impact of developing neuromas [24] . While such analgesic techniques likely have no impact on anatomical changes post-nerve transection, whether prolonged dense blockade of distal nociceptive signals prevents chronic sensitization is an essential question yet to be answered [15, 25] .
The quality of the myodesis may also present technical challenges to the surgeon, especially after traumatic injury. The steadfast attachment of muscle to bone in the rehabilitation period is particularly important in the case of a below-knee amputation where both weight-bearing and joint motion are required for proper ambulation. Some patients may also require staged amputations (secondary to infection, trauma, etc.) and therefore experience numerous trips to the operating room. In these cases, a comprehensive plan must be established allowing for both a tailored and prolonged analgesic strategy.
As with all regional anesthetic and analgesic techniques, a thorough understanding of the level of amputation and neuroanatomical distributions is essential if one is planning on utilizing either neuraxial or peripheral analgesic techniques. We review these anatomic considerations for the purpose of optimizing regional analgesic techniques in Tables 2 and 3 . Upper extremity amputations largely can be covered with brachial plexus blockade, but proximal amputations may also involve other nerve distributions (i.e., cervical plexus, intercostobrachial nerve, etc.). Lower extremity amputations almost always involve both lumbar and sacral plexus innervation except in distal foot amputations, therefore, dual plexus blockade should always be considered for optimal analgesic coverage.
Risk Factors for Significant Acute Pain Following Amputation
Pre-amputation pain is a recognized risk factor for significant postoperative pain. Hanley et al. surveyed 86 patients undergoing amputation measuring PLP and RLP intensity postoperatively and found that preoperative pain strongly predicted both PLP and RLP within the first postoperative week [14] . In a similar fashion, Nikolajsen et al. demonstrated that the intensity but not the duration of pre-amputation pain was associated with significant early RLP and PLP [26] . This association between preoperative symptoms and postoperative pain implies that symptoms and not the surgical insult should dictate early intervention when appropriate [27] .
In addition to pre-amputation pain, preoperative opioid use and certain psychological factors also place patients at risk for significant immediate post-amputation pain. Roullett et al. in an observational study involving patients undergoing lower limb amputation stratified patients post hoc depending on their preoperative usage of opioids [28] . All patients received general anesthesia and preoperative perineural catheter placement. Those taking preoperative opioids demonstrated significantly higher postoperative opioid use [median of 52 (13-133) mg IV Morphine Sulfate vs. 0 Table 2 Lower amputation type and corresponding neuroanatomy Kent et al.
(0-26) mg IV Morphine Sulfate] and significantly higher postoperative pain scores [28] . Aside from opioid use, preoperative anxiety (rather than generalized anxiety) has also been suggested to predict the presence and severity of early RLP and PLP postoperatively [12] . Patients utilizing opioids for a notable duration or dosage along with patients expressing clinically significant levels of anxiety should be considered for stratification to aggressive postoperative analgesic regimens.
Perioperative Management

Role of the Acute Pain Physician
A key component of the multidisciplinary approach for patients undergoing amputation is the inclusion of a comprehensive acute pain medicine service. Ideally, such a service engages patients preoperatively and remains the key if not sole source for analgesic administration until postoperative pain is well controlled. Depending on system resources, acute pain medicine services should be available for days to weeks postoperatively for continued consultation and management.
Application of pharmacologic, interventional, and integrative methods is essential to minimize the probability of significant suffering within the perioperative period from both somatic and acute neuropathic pain. Additionally, such teams are essential in stratifying patients into risk categories and choosing appropriate regimens that minimize the risk of adverse events. Patients undergoing amputation for dysvascular conditions are often elderly and require complex medical management for comorbidities such as renal insufficiency, coronary artery disease, systemic infection, and multifactorial dementia, all of which increase the risks of adverse events related to pharmacologic or interventional modalities [29] [30] [31] . Therapeutic interventions may also be limited in patients with frail health or on anticoagulant medications [32] . A comprehensive strategy by the acute pain physician is paramount to alleviate suffering in the immediate postoperative period and to minimize risk.
Multidisciplinary Approach
Perioperative acute pain management in patients undergoing amputation is only a portion of the rehabilitative care needed to optimize functional outcomes. It is mandatory that acute pain physicians advocate for a multidisciplinary care approach involving both medical and rehabilitative services. Patients undergoing amputation are at a higher risk for immediate complications (myocardial infarction, wound infection, renal failure) as well as depression, poor physical function secondary to pain, and impaired social satisfaction [33] [34] [35] [36] . Teams that include physical therapists, occupational therapists, mental health providers, social workers, primary care practitioners, surgical specialties, and acute pain medicine specialists are essential to address the myriad of variables that impact both the immediate recovery and the longer-term functional rehabilitation.
In 2008, the Veteran's Health Administration provided a comprehensive clinical practice guideline which addressed the multidisciplinary care of the amputation patient extending from the preoperative phase through long term follow up [37, 38] . Similar to other rehabilitative commentary, the role of pain management is essential during all phases of rehabilitation, including early postoperative range of motion Table 3 Upper extremity amputation type and corresponding neuroanatomy Perioperative Pain Management Following Amputation exercises and positioning [39] . Such interdisciplinary and analgesic approaches in vascular disease patients undergoing amputation have led to both earlier hospital discharge and improved mortality 1 year post-amputation [40] . Thus, acute pain medicine has significant potential to provide benefit at each stage of rehabilitation including the transition to discharge.
Pharmacologic Modalities (Table 4) Gabapentanoids Numerous well-designed clinical trials and metaanalyses assert that the perioperative use of gabapentin has both an opioid sparing and analgesic impact [41] [42] [43] . Gabapentin's beneficial role has been noted across various surgical categories to include orthopedic surgery, mastectomy, abdominal surgery, and otolaryngology [44] . In one trial involving brachial plexus surgery, gabapentin use was associated with greater than 20% reduction in both pain scores and opioid use in the acute postoperative period [44] .
The benefits of gabapentin, nonetheless, have not been consistently demonstrated. This may be due to patientspecific factors, inefficacy for certain surgeries, inadequate dosing, insufficient statistical power, or analgesic effects masked by the use of multimodal protocols. For example, Adam et al. administered a single dose of gabapentin versus placebo preoperatively to patients undergoing shoulder arthroscopy with concomitant use of an interscalene block [45] . No significant difference in 24-hour pain scores or opioid utilization was observed [45] . One might postulate that a single dose of gabapentin would have little effect during the duration of a well-performed brachial plexus block. Similarly, in a randomized, controlled, double-blind study, Gilron et al. found no difference in opioid use or functional outcomes in hysterectomy patients treated with a triple non-opioid drug regimen (gabapentin, meloxicam, acetaminophen) versus a double non-opioid drug regimen (various combinations of the above) [46] . A multimodal threshold may exist for certain surgeries whereby additional agents add little benefit.
To date, no study exists where acute pain outcomes are measured within the first 7 days following limb amputation with the administration of gabapentin. Instead, most studies have focused on the use of gabapentin for the treatment of persistent post-amputation pain (RLP and PLP) with mixed success [47, 48] . For instance, Nikolajsen et al. randomized 41 patients undergoing amputation to either placebo or an escalating 30 day regimen of gabapentin. No differences were seen in RLP/PLP intensity at subacute time points (7 days, 14 days, 30 days) or remote time points (3 months, 6 months). Unfortunately, pain scores in the immediate postoperative setting were not reported. However, its effectiveness as an opioid-sparing agent in neurologic surgeries (i.e., brachial plexus surgery) implies a potential role in amputation, particularly when regional anesthesia is contraindicated [44] .
Despite this lack of acute pain data in amputation surgery, many acute pain teams extrapolate positive studies in other surgical cohorts and utilize gabapentenoids in the periamputation period. This use must be balanced with risks of reported adverse events (sedation, dizziness, respiratory depression, and visual changes) as patients undergoing amputation are characterized by a notable incidence of coronary artery disease, renal insufficiency, and advanced age [49] [50] [51] [52] [53] ). Thus, vigilance is required with the use of gabapentin in this population, and dosing adjustments should be made based on the burden of comorbidities [41, 54] . Caution should also be exercised in renal disease given drug excretion. While a variety of dosing regimens have been described, preoperative dosing followed by thrice daily dosing has been utilized as part of a multimodal strategy in a variety of surgeries, and may be extrapolated to the amputation population, taking into account co-morbid medical illness [41, 55] .
Similar to gabapentin, pregabalin has shown efficacy in decreasing opioid usage within the first 24 hours postoperatively [56, 57] . In addition to an opioid sparing effect in the acute postoperative period, a two week course of pregabalin has been shown to decrease neuropathic pain symptoms up to 6 months postsurgery [58] . However, the incidence of side effects (sedation and dizziness) was significant in the treatment group who received a 300 mg loading dosing following by 150 mg twice daily tapered over 2 weeks. As noted in a recent literature review, such worrisome side effects have been noted in numerous other studies across various surgical groups [51] . Thus, while pregabalin is an option in the immediate postamputation setting, similar vigilance is required as with gabapentin administration.
NMDA Receptor Antagonists
NMDA receptor antagonists, particularly ketamine, have a well-established role in providing opioid sparing analgesia within the perioperative setting. Jouguelet-Lacoste et al. in a comprehensive review of available literature highlighted ketamine's ability to reduce opioid use 30-40% in the immediate post-surgical period albeit with mixed results in the reduction of pain scores [59] Ketamine has also shown efficacy in acute neuropathic pain states following spinal cord injury [60] .
NMDA antagonists have a consistent safety record within the perioperative period. Numerous metanalyses and reviews have documented no significant difference in psychomimetic effects during the administration of ketamine compared to standard opioid therapy [59, 61, 62] . Furthermore, no detrimental cardiopulmonary events have been documented compared to placebo during the utilization of subanesthetic infusions. Additionally, numerous studies have reported improved respiratory parameters such as improved spirometric function or decreased incidences of desaturation [63, 64] . No dose correction is required in patients with chronic kidney disease although caution should be exhibited when using ketamine in elderly patients [65] .
Regarding the efficacy of ketamine immediately following amputation, results are mixed and several pertinent studies have focused on time points outside of the immediate postoperative period. Dertwinkel at el. in a small prospective observational study characterized residual limb and phantom pain severity/incidence in the immediate postoperative setting in patients receiving a 48 hour ketamine infusion along with catheter-based analgesia (epidural or peripheral nerve catheter) [66] . Immediate mean PLP was significantly decreased in the ketamine group but no difference was seen in maximum pain scores or in RLP. Conversely, Hayes et al. observed no difference in opioid use within the first 24 hours and no difference in pain severity at 3 days and 6 days in a randomized controlled trial of patients undergoing amputation and receiving a 72-hour ketamine infusion [67] .
In addition to the intravenous administration of ketamine, other routes and formulations have also been studied for possible benefit in the immediate postoperative setting. Epidural ketamine has been studied in a limited fashion [68] . However, given potential neurotoxic effects of this medication, we will not review this data here [69] . Memantine (an oral NMDA antagonist) has also been evaluated for its possible benefit in the immediate post-amputation setting. In a small prospective study, Schley et al. randomized patients undergoing upper extremity amputations to an escalating 4-week dose of memantine versus placebo in addition to a 7-day axillary perineural catheter [70] . Patients who received memantine required fewer local anesthetic boluses postoperatively and had a lower incidence of phantom pain at all time points until 6 months.
Although there is limited evidence for the perioperative analgesic effect of NMDA antagonists after amputation surgery, there is an extensive body of literature suggesting an analgesic and opioid sparing benefit in other surgical models [59, 62, 71, 72] . However, proper patient stratification must be utilized as the use of perioperative ketamine infusion has been questioned in situations where patients are opioid naïve and are already receiving a well-designed multimodal regimen [73, 74] .
Calcitonin
Calcitonin has also been evaluated in the acute perioperative period for treatment of acute PLP. While its exact analgesic mechanisms remain unclear, enhanced release of b endorphins and interaction with descending serotonergic pathways have been hypothesized [75, 76] .
In a small study involving patients with acute PLP within the first 7 days following surgery, Jaeger et al. randomized patients to receive an infusion of calcitonin versus placebo. No clear analysis of RLP was provided.
Patients receiving calcitonin were noted to have significant decreases in PLP severity and frequency; however, evidence for a sustained impact was unclear due to non-standardized postoperative analgesic regimens [77] . Unlike most studies evaluating PLP where all patients undergoing amputation were enrolled prior to surgery regardless of whether they reported PLP postoperatively, this study enrolled only patients with acute PLP. Effectiveness of calcitonin has not been repeated in a subsequent study of patients with persistent PLP [78] .
NSAIDS/Acetaminophen
Acetaminophen has a long history as a non-opioid adjunct in the perioperative setting. Numerous nonamputation specific trials and meta-analyses have established its analgesic and opioid sparing properties [79] [80] [81] . While care must be taken to avoid surpassing maximum daily dosages (i.e., avoidance of combination analgesics containing acetaminophen, no more than 3 grams/day if over 50kg), acetaminophen should be utilized in the majority of patients undergoing amputation.
Non-steroidal anti-inflammatory medications should also be strongly considered within any multimodal regimen. NSAIDS have even been suggested to play a role in prevention of heterotrophic ossification following amputation [82] . However, in patients undergoing amputation, consideration must be given to comorbidities that may be exacerbated by their administration. While no definitive evidence suggests harm in the short perioperative use of NSAIDS, caution should be used in administering such agents to the elderly or patients with existing coronary artery disease, congestive heart failure, renal insufficiency, concurrent ACE inhibitor usage, hypovolemia, and hypotension [65, [83] [84] [85] .
Interventional Modalities (Tables 4 and 5)
Both neuraxial and peripheral nerve catheter techniques have an established role in perioperative analgesia as measured by decreased pain intensity scores, opioid sparing analgesia, earlier discharge, and improved cardiopulmonary variables (decreased myocardial infarction and pneumonia in high risk populations) [86] [87] [88] . Furthermore, a preventive analgesic role for such techniques has been suggested, but is outside the scope of this review [89] . Catheter-based analgesia has been studied in periamputation pain management, but conclusions are inconsistent given methodological variability in timing of placement, choice of medication, and duration of infusion. Most studies to date have primarily focused on the prevention of persistent PLP/RLP and the analgesic effect these interventions provide in the immediate postoperative period have frequently been analyzed only as secondary outcomes [15, 90] .
Neuraxial Analgesia (Table 4) Studies involving the use of epidural analgesia have primarily focused on the prevention of PLP along with a focus on the timing of epidural placement. Such studies by Bach, Jahangiri, and Nikolajsen focused on the longterm preventive effect of epidural analgesia with a paucity of information in the acute post-operative period [91, 92] . Shifting focus toward the acute postoperative period, Lambert et al. conducted a randomized prospective comparative trial between epidural and surgically placed perineural catheters [93] . Patients receiving epidural analgesia displayed superior pain scores within the first three postoperative days compared to patients receiving surgically placed distal perineural catheters. Of note, patients in the epidural group underwent placement 24 hours prior to surgery resulting in a significant preoperative pain benefit whereas patient in the surgical perineural group did not receive catheter placement until surgery.
Expanding on this body of literature, Karanikolas et al. addressed the effects of multiple perioperative analgesic interventions on both acute and chronic pain [94] . Study enrollment included patients with peripheral arterial disease suffering from severe ischemic pain. Five treatment groups were evaluated in different combinations with the use of epidural analgesia and/or patient-controlled analgesia (PCA) with fentanyl in the preoperative, intraoperative, and postoperative phase. Epidural placement and PCA initiation occurred 48 hours prior to surgery and were continued 48 hours after surgery. All groups, whether receiving preoperative epidural analgesia or preoperative fentanyl PCA, had a decrease is VAS scores from 80-90 mm to 0-20 mm prior to surgery. All groups reported a significant benefit when compared to controls in decreasing immediate postoperative pain. With the exception of one group, all groups displayed decreased PLP prevalence/intensity at 6 months compared to controls. Such results suggest that effective acute analgesia is critical, regardless of analgesic regimen, and may decrease the incidence of chronic pain.
The role of epidural analgesia is further supported by Ong et al. in a survey of patients following lower extremity amputation. Patients reported superior pain control with epidural analgesia during the first week postsurgery compared to patients who received opioids alone [95] . Whether traumatic or dysvascular in nature, preoperative epidural placement should be implemented. Although consideration must always be given to anticoagulation needs, altered hemodynamics, infection risk, and the detriment of immobility due to limb weakness, it is increasingly clear that maximizing the benefits of analgesic catheter techniques may require more prolonged infusion [15] . In this setting, transition to perineural catheter(s) may provide benefit when prolonged therapy is desired.
Perineural Catheters (Table 5) Perineural catheters have been utilized in various settings with the goal of site-specific analgesia that circumvents the need for epidural analgesia and its inherent side effects or inability to provide adequate coverage (i.e., upper extremity injuries). In patients undergoing amputation, techniques have included both placement of a distal catheter directly onto the nerve at the time of surgical resection and proximal catheters placed perioperatively by the anesthesiologist.
Distal Perineural Analgesia
Distal perineural catheters were initially described by Malawer in 1991 [96] . These catheters are placed inside the relevant nerve sheath at the time of nerve transection and infused with local anesthetic during the postoperative period. Bosanquet et al. performed a meta-analysis of all trials involving the surgical placement of perineural catheters in 2015 [97] . Studies demonstrated variability in underlying disease, surgical type and catheter location. Only two of the studies were considered to be of "high quality." Despite this, pooled analysis displayed a significant opioid sparing benefit (up to 50% in the perioperative period) but no impact on acute pain scores. However, when compared to epidural analgesia, surgically placed perineural catheters display inferior analgesia in the immediate postoperative period following amputation [93] .
Proximal Perineural Analgesia
Few studies have systematically assessed the role of proximally placed perineural catheters in the setting of acute pain following amputation. Feasibility has been documented in case reports and also in the military's aggressive application of continuous perineural catheters in combat wounded [98] . Notably in traumatic amputees, continuous proximal perineural catheters placed within the first 24 hours following battlefield injury result in significant pain relief [99] . Such catheters have remained in place for prolonged periods (median 9 days, range: showing no significant increase in complications compared to comparative civilian studies of shorter duration [100] [101] [102] .
Consistent with the literature on epidural analgesia, studies of proximal perineural catheters have often only included immediate post-amputation pain measures as secondary outcomes. Roullett et al. in a prospective observational study noted minimal median pain scores on postoperative days 1-3 in opioid naïve patients receiving preoperative sciatic perineural catheters. Blocks were initially performed with 0.75% ropivacaine followed by a 0.2% ropivacaine infusion. However, Borghi et al. in a prospective observational study in patients undergoing amputation observed that the majority of patients reported severe and intolerable pain within the first 24 postoperative hours despite the use of perineural catheter infusions [15] . Unique to this study, perineural catheters were continued with 0.5% ropivacaine for a median duration of 30 days. After 4-5 weeks of perineural infusion, almost no patients reported significant PLP/ RLP.
Overall, further studies are needed to characterize the analgesic capability of continuous perineural catheters in the immediate postamputation setting. However, the possibility of prolonged perineural catheters playing a preventive role is encouraging and is similar to studies of epidural or paravertebral blockade displaying preventive capabilities in other surgical subtypes [89] . Also, the dosage and duration of such catheters may play a significant role as well. Nonetheless, proximal perineural catheters provide a feasible option of continuous analgesia that can cover numerous nerve distributions including the overlying skin of the amputated limb, may remain in place for extended periods of time, and can be titrated depending on individualized needs.
Interventional Summary
Current literature is significantly heterogeneous due to different study designs, catheter techniques, dosing regimens, and outcome metrics. Epidural-based analgesia provides the capability to deliver dense bilateral sensory loss along with synergistic additives (opioids, alpha 2 agonists, etc.) that may enhance analgesia compared to more peripheral techniques. However, depending on population specific concerns (anticoagulation, polytrauma with multiple injuries to an amputated limb, upper extremity amputation, etc.), epidural analgesia may not always be the ideal choice. On the other hand, continuous perineural catheter placement is rarely contraindicated and can provide almost full limb sensory coverage for an extended duration. Furthermore, if proximal perineural techniques are chosen, one should strongly consider placing multiple catheters to maximize the neuroanatomical distributions covered by the infusion of local anesthetic.
There seems to be an inferior and limited role for surgically placed distal perineural catheters. Placement is usually on a single nerve where nociception in either upper or lower extremity amputation involves numerous nerve distributions that contribute to acute pain. In addition, such catheters have no impact on providing analgesia to overlying skin and connective tissue structures in such a distal location. However, when epidural or proximal perineural catheter placement is not technically feasible or suboptimal (hemi-pelvectomy, shoulder disarticulation, etc), surgically placed perineural catheters may be considered.
While further comparative studies are needed, consideration must also be given to dosing regimens as a wide variety of concentration and infusion schemes are noted within the literature. The predominance of studies have utilized higher concentrations of local anesthetics (0.25% bupivacaine or 0.5% ropivacaine) for initial bolus and infusion dosing which may play an important role in dampening the peripheral nociceptive load following such a surgical insult. However, literature to the contradictory does exist, which describes poorly controlled severe postop pain with the higher 0.5% ropivicaine concentration. This contrasting data further accentuates the need for comparative studies on dose response and drug duration studies. Additionally, in studies utilizing epidural analgesia, a variety of additives such as clonidine or opioids have also been utilized each with unique analgesic mechanisms at the level of the spinal cord [90] [91] [92] .
Remaining unclear is what possible role such additives may play in the treatment of immediate postamputation pain or persistent post-amputation pain prevention.
Conclusion and Future Directions
While numerous studies have been conducted regarding persistent post-amputation pain and possible preventive analgesic strategies, the impact of these interventions on acute and subacute PLP/RLP remains poorly studied. There is an immediate need for research that compares analgesic approaches such as perineural/neuraxial catheters, gabapentin, and NMDA antagonists measuring the comprehensive pain experience from preoperative time points and extending through the immediate and subacute postoperative phases. Such comparative studies should focus on specifying effective regimens instead of single modality techniques. While initial results have suggested a beneficial role for prolonged perineural catheters, further comparative studies are needed to define if such a benefit exists and, if so, what is the optimal duration of perineural infusion.
While focusing on the acute/subacute phase following amputation is essential, reliance on pain intensity and opioid use as primary outcomes must be reconsidered. Alternatively, pain trajectories early in the postoperative period can predict persistent pain with trends in pain subtypes (neuropathic vs non-neuropathic) possibly proving a better identifier of patients at risk for persistent pain [103, 104] . The incidence of PLP can range from 60% to 80% of amputees with a much smaller incidence (5-10%) of debilitating PLP [19] . This disparity establishes the need for multidimensional measurements of function and bio-psychosocial impact starting in the immediate postamputation phase to aid in characterizing the true impact of RLP/PLP [33] . A focus on improved measurement may aid in predictive modeling in the preoperative phase and expand the therapeutic options in the postoperative Figure 1 Perioperative amputation analgesic pathway. Suggested pharmacologic and interventional modalities with consideration for patients at risk for severe or prolonged postoperative pain.
phase past traditional pharmacologic and interventional options. Furthermore, such multidimensional models may identify at-risk populations that warrant intensive follow up during the subacute rehabilitative phase [103] .
At present, aggressive preoperative analgesic regimens should be initiated in all patients undergoing amputation ( Figure 1 ). Interventional modalities should serve as the primary approach for providing extended analgesia. If preoperative pain is significant, neuraxial or perineural catheters should be placed prior to the day of surgery and maintained postoperatively until both RLP/PLP symptoms are well tolerated as this may provide a persistent benefit. Pharmacologic adjuncts should be utilized early and continued postoperatively while taking into account the risk for postoperative adverse events. It is paramount that the acute pain medicine physician continues to monitor and follow patients undergoing amputation until discharge to provide individualized inpatient pain medicine and facilitate a smooth transition to outpatient pain care. 
